Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Fred Hutchinson Cancer Center
Mayo Clinic
OHSU Knight Cancer Institute
British Columbia Cancer Agency
Mayo Clinic
City of Hope Medical Center
University of California, San Francisco
Mayo Clinic
Thomas Jefferson University
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
Mayo Clinic
The University of Texas Health Science Center at San Antonio
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of Washington
Alliance for Clinical Trials in Oncology
Academic and Community Cancer Research United
Hackensack Meridian Health
National Tuberous Sclerosis Association
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Augusta University
Augusta University
Mayo Clinic
UNICANCER
Mayo Clinic
Beijing Tiantan Hospital
Alliance for Clinical Trials in Oncology
Mayo Clinic
Mayo Clinic
Fudan University
University Hospital, Montpellier
Samsung Medical Center
Data Collection Analysis Business Management
Centre Leon Berard
Southern Medical University, China
Ohio State University Comprehensive Cancer Center
CHU de Reims
Sun Yat-sen University
Assistance Publique Hopitaux De Marseille
The Netherlands Cancer Institute